QGEN - QIAGEN N.V.
46.88
-0.770 -1.642%
Share volume: 1,975,041
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$47.65
-0.77
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 05-01-2024 | 08-02-2024 | |
| Assets | |||
| Total Assets | 5.806 B | 5.585 B | |
| Current Assets | 1.891 B | 1.830 B | |
| Inventories | 401.745 M | 321.750 M | |
| Other Current Assets | 251.992 M | 262.489 M | |
| Short Term Investments | 251.992 M | 262.489 M | |
| Total Receivables | 343.892 M | 355.300 M | |
| Current Cash | 893.133 M | 890.240 M | |
| Total Non-current Assets | 3.915 B | 3.755 B | |
| Property Plant Equipment | 762.530 M | 717.765 M | |
| Other Assets | 197.215 M | 219.127 M | |
| Intangible Assets | 502.006 M | 345.456 M | |
| Goodwill | 2.449 B | 2.449 B | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 5.806 B | 5.585 B | |
| Total liabilities | 2.206 B | 2.179 B | |
| Total current liabilities | 1.025 B | 1.035 B | |
| Accounts Payable | 75.329 M | 76.061 M | |
| Other liabilities | 268.320 M | 235.545 M | |
| Current long term debt | 590.523 M | 492.699 M | |
| Long term debt | 912.814 M | 908.920 M | |
| Other liabilities | 268.320 M | 235.545 M | |
| Minority interest | 0.000 | 0.000 | |
| Total Shareholder equity | 3.600 B | 3.405 B | |
| Common stock | 223.835 M | 221.989 M | |
| Retained earnings | 2.486 B | 2.265 B |